Treatment of myelodysplastic syndrome: Questions raised by the azacitidine experience

被引：9
|
作者：
Kantarjian, HM [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 10期
关键词：
D O I：
10.1200/JCO.2002.20.10.2415
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2415 / 2416
页数：2
相关论文
共 50 条
  • [1] Azacitidine for the treatment of myelodysplastic syndrome
    Cataldo, Vince D.
    Cortes, Jorge
    Quintas-Cardama, Alfonso
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (07) : 875 - 884
  • [2] Treatment of Myelodysplastic syndrome with azacitidine and erythropoietin
    Limaye, Sewanti
    Lipshitz, Jay
    Dulala, Renuka
    Patel, Dilip
    [J]. BLOOD, 2007, 110 (11) : 230B - 230B
  • [3] Clinical Experience with Azacitidine In Secondary Myelodysplastic Syndrome In Spain
    Garcia, Regina
    Sanz, Guillermo F.
    de Miguel Llorente, Dunia
    Nomdedeu, Benet
    Mar Romero, Ma
    Bernal, Teresa
    Besalduch, Juan
    Amutio, Elena
    Brunet, Salut
    [J]. BLOOD, 2010, 116 (21) : 772 - 772
  • [4] Azacitidine for Treatment of Therapy Related Myelodysplastic Syndrome
    Komrokji, Rami S.
    Al Ali, Najla H.
    Alrawi, E.
    Padron, Eric
    Perkins, Janelle
    Field, Teresa
    Lancet, Jeffrey E.
    List, Alan F.
    [J]. BLOOD, 2011, 118 (21) : 745 - 746
  • [5] Treatment outcome of 5′-azacitidine for myelodysplastic syndrome
    Kim, Y. K.
    Kim, H. J.
    Song, J. E.
    Kim, S. E.
    Ahn, J. S.
    Yang, D. H.
    Lee, J. J.
    [J]. LEUKEMIA RESEARCH, 2013, 37 : S110 - S110
  • [6] Treatment of intermediate and high risk myelodysplastic syndrome patients with azacitidine. The Hellenic experience
    Pappa, V.
    Papageorgiou, S.
    Tsirigotis, P.
    Dervenoulas, J.
    Girkas, K.
    Papageorgiou, E.
    Poulakidas, H.
    Papadaki, E.
    Galanopoulos, A.
    Vervessou, E.
    Panayotidis, P.
    Zomas, A.
    Symeonidis, A.
    Economopoulos, T.
    [J]. LEUKEMIA RESEARCH, 2009, 33 : S134 - S135
  • [7] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
    Lin, Che-Hung
    Yeh, Su-Peng
    Lin, Tze-Yi
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1925 - 1926
  • [8] INFECTIONS IN PATIENTS WITH MYELODYSPLASTIC IN TREATMENT WITH AZACITIDINE: EXPERIENCE OF A CENTRE
    Amores Contreras, M. G.
    Sanchez Fontarigo, N.
    Diaz Goizueta, M.
    Requena Rodriguez, M. J.
    Condori Arenas, M.
    Sanchez Godoy, P.
    [J]. HAEMATOLOGICA, 2015, 100 : 263 - 263
  • [9] Azacitidine is effective for the treatment of myelodysplastic syndrome and accompanied Sweet syndrome
    Che-Hung Lin
    Su-Peng Yeh
    Tze-Yi Lin
    [J]. Annals of Hematology, 2015, 94 : 1925 - 1926
  • [10] Treatment of Advanced Myelodysplastic Syndrome With Demethylating Agents: Azacitidine
    Ades, Lionel
    Itzykson, Raphael
    Fenaux, Pierre
    [J]. SEMINARS IN HEMATOLOGY, 2012, 49 (04) : 323 - 329
12345